Outcomes and excess costs among patients with cardiovascular disease

QR Code

Outcomes and excess costs among patients with cardiovascular disease

Objective: To report on two-year cardiovascular (CV) event rates and quantify the cost of cardiovascular disease using the Australian Reduction of Atherothrombosis for Continued Health (REACH) registry. Methods: Prospective registry of 2873 patients with multiple risk factors (MRF), coronary artery...

Full description

Bibliographic Details
Main Authors:	Ademi, Z., Liew, D., Zomer, E., Gorelik, A., Hollingsworth, B., Steg, P., Bhatt, D., Reid, Christopher
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/24944

Similar Items

Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)

Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)

Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort
by: Ademi, Z., et al.
Published: (2013)

Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry
by: Ademi, Z., et al.
Published: (2011)

Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry
by: Ariyaratne, T., et al.
Published: (2013)

Economic implications of obesity among people with atherothrombotic disease
by: Ademi, Z., et al.
Published: (2010)

Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study
by: Si, Si, et al.
Published: (2018)

Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms
by: Zomer, E., et al.
Published: (2014)

The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)

Overview of pharmacoeconomic modelling methods
by: Ademi, Z., et al.
Published: (2013)

Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)

The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-Year follow-up data from the australian REACH registry
by: Ademi, Z., et al.
Published: (2013)

Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization
by: Elbez, Y., et al.
Published: (2016)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis
by: Zomer, E., et al.
Published: (2013)

Outcomes from the REACH registry for Australian general practice patients with or at high risk of atherothrombosis
by: Reid, Christopher, et al.
Published: (2012)

An international model to predict recurrent cardiovascular disease
by: Wilson, P., et al.
Published: (2012)

More or less physical activity and the effect on cardiovascular mortality in a high-risk population
by: Zomer, E., et al.
Published: (2011)

Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The 'old' versus the 'new' Framingham equation
by: Zomer, E., et al.
Published: (2011)

Epidemiology of cardiovascular disease
by: Reid, Christopher, et al.
Published: (2016)

Prevention of Cardiovascular Disease
by: Owen, A., et al.
Published: (2012)

Cost-effectiveness of renal denervation therapy for treatment-resistant hypertension: A best case scenario
by: Chowdhury, E., et al.
Published: (2018)

Androgens And Cardiovascular Disease In Men
by: Yeap, B., et al.
Published: (2019)

Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling
by: Ruwanpathirana, T., et al.
Published: (2015)

Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
by: Chowdhury, E., et al.
Published: (2014)

The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis
by: Brady, S., et al.
Published: (2009)

Cardiovascular disease in Australia: Calm before a new storm?
by: Reid, Christopher
Published: (2013)

Cardiovascular disease in patients with chronic kidney disease
by: Pilmore, H., et al.
Published: (2014)

IMPACT OF EXCESS WEIGHT ON THE RELATIONSHIP BETWEEN BLOOD PRESSURE AND CARDIOVASCULAR DISEASE: THE ASIA PACIFIC COHORT STUDIES COLLABORATION
by: Tsukinoki, R., et al.
Published: (2011)

Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications
by: Peters, S., et al.
Published: (2015)

Applying a framework to assess the impact of cardiovascular outcomes improvement research
by: Sarkies, Mitchell, et al.
Published: (2021)

Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis
by: De Courten, B., et al.
Published: (2008)

A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era
by: Ariyaratne, T., et al.
Published: (2016)

Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older persons
by: Liew, S.M., et al.
Published: (2022)

Excess Cancer Mortality in Psychiatric Patients
by: Kisely, S., et al.
Published: (2008)

Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention
by: Ramzy, J., et al.
Published: (2019)

DEVELOPMENT OF A CARDIOVASCULAR MORTALITY RISK PREDICTION MODEL FOR PARTICIPANTS IN THE OHASAMA STUDY
by: Huq, M., et al.
Published: (2014)

Population screening an important step in identifying and increasing awareness of cardiovascular disease in developing countries
by: Davidson, P., et al.
Published: (2012)

PREDICTIVE PERFORMANCE OF ECHOCARDIOGRAPHIC PARAMETERS ON CARDIOVASCULAR EVENTS AMONG THE ELDERLY TREATED HYPERTENSIVE PATIENTS
by: Chowdhury, E., et al.
Published: (2015)

Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease
by: Kalra, P., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_52h86duvk2r05bnf0artm78ntd